| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |